Stock ALPN ALPINE IMMUNE SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Quotes Alpine Immune Sciences, Inc.

Equities

ALPN

US02083G1004

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
64.97 USD +0.02% Intraday chart for Alpine Immune Sciences, Inc. 0.00% +240.87%
May. 20 Alpine Immune Sciences, Inc.(NasdaqGM:ALPN) dropped from NASDAQ Composite Index CI
May. 20 Vertex Pharmaceuticals Incorporated completed the acquisition of Alpine Immune Sciences, Inc. from a group of shareholders. CI

Performance

1 day+0.02%
Current month+0.59%
1 month+0.64%
3 months+86.05%
6 months+331.12%
Current year+240.87%
1 year+556.26%
3 years+509.47%
5 years+1,270.68%

Volumes

markets
Daily volume
4 288 333
Estimated daily volume
4 288 333
Record volume 1
40 084 750
Record volume 2
34 587 931
Record volume 3
12 234 018
Capital turnover ratio
0.00
Float rotation
0.00

Basic data

Capitalization (USD)
4 456 781 329
Net sales (USD)
58 876 000
Number of employees
142
Sales / Employee (USD)
414 620
Free-Float
95.35 %
Free-Float capitalization (USD)
4 249 538 269

Highs and lows

1 month
64.50
Extreme 64.5
65.00
Current year
17.32
Extreme 17.32
65.00
1 year
8.33
Extreme 8.33
65.00
3 years
4.82
Extreme 4.82
65.00
5 years
2.05
Extreme 2.05
65.00
10 years
2.05
Extreme 2.05
65.00

Indicators

Moving average 5 days
64.96
Moving average 100 days
39.56
Price spread / (MMA5)
-0.01%
Price spread / (MMA100)
-39.11%
RSI 9 days
0.00
RSI 14 days
0.00

Sector Comparison - Bio Therapeutic Drugs

Name Change 5d. change 1st Jan change 1-year change Capi.
ALPINE IMMUNE SCIENCES, INC. Stock Alpine Immune Sciences, Inc.
+0.02%0.00%+240.87%+556.26% 4.46B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.20%+1.10%+9.83%+35.42% 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
-1.20%-2.09%+10.80%+34.22% 105B
BIONTECH SE Stock BioNTech SE
-2.94%+2.20%-10.84%-10.61% 22.71B
ARGENX SE Stock argenx SE
+0.47%-0.91%-1.57%-9.94% 21.83B
GENMAB A/S Stock Genmab A/S
-0.93%-3.37%-10.23%-31.40% 18.18B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-0.38%-3.32%-41.92%-35.99% 16.52B
BEIGENE, LTD. Stock BeiGene, Ltd.
+0.26%-8.53%-15.11%-35.37% 16.01B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+0.77%-0.05%+6.62%+54.00% 14.14B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
-8.21%-12.23%+17.53%-10.64% 10.71B
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
+0.65%-2.98%-30.73%-33.98% 7.6B
CEREVEL THERAPEUTICS HOLDINGS, INC. Stock Cerevel Therapeutics Holdings, Inc.
-0.80%-1.84%-3.30%+22.75% 7.47B
VAXCYTE, INC. Stock Vaxcyte, Inc.
-0.09%-6.72%+9.39%+40.29% 7.47B
ASCENDIS PHARMA A/S Stock Ascendis Pharma A/S
-2.36%+3.65%+1.10%+41.87% 7.3B
VIKING THERAPEUTICS, INC. Stock Viking Therapeutics, Inc.
+4.16%+1.76%+251.21%+206.71% 7.21B
WUXI BIOLOGICS (CAYMAN) INC. Stock WuXi Biologics (Cayman) Inc.
-2.21%-12.92%-61.28%-72.71% 6.25B
Average-0.96%-2.62%+23.27%+46.93%
Weighted average by Cap.-1.40%-1.30%+8.94%+26.20%

Historical data

DateOpeningHighLowEnd-of-dayVolume

Chart Alpine Immune Sciences, Inc.

Chart Alpine Immune Sciences, Inc.
More charts

Monthly variations

Annual change

2024+240.87%
2023+159.32%
2022-46.93%
2021+9.92%
2020+228.13%
2019+4.35%
2018-67.14%
2017+17.28%
  1. Stock Market
  2. Equities
  3. ALPN Stock
  4. Quotes Alpine Immune Sciences, Inc.